Nepal is the second country in the world to have signed agreements with GAVI to obtain 4 million doses of Moderna vaccines through the COVAX cost-share option, which is funded by the World Bank. The country’s COVID-19 vaccination portfolio will be diversified and strengthened as a result of this.
“Nepal is an early adopter of the COVAX cost-sharing programme, and I am delighted to report that, despite very difficult circumstances, we have finalised an agreement to provide safe and highly effective vaccinations to Nepal,” said Umesh Shrestha, Minister of State for Health and Population. “Moderna vaccinations have assisted in expanding alternatives for vaccinating Nepalis over the age of 12 and hastened Nepal’s path toward a safer post-COVID world.”
The delivery of these vaccines is planned to begin in March 2022, contributing to Nepal’s objective of vaccinating at least 72 percent of its population, as well as children aged 12 to 17 for whom the Moderna vaccine is safe and effective.
“We are proud to assist the people and government of Nepal, as well as our development partners, in purchasing safe and effective vaccinations through the COVAX facility,” said Faris Hadad-Zervos, World Bank Country Director for the Maldives, Nepal, and Sri Lanka. “This is an important component of our overall COVID response since it helps to satisfy emergency health demands while also building the healthcare and vaccination delivery system.”
The World Bank has committed $104 million to the Nepalese government’s health response to the epidemic, with $67.5 million set aside for the purchase and deployment of COVID-19 vaccinations. The project brought in 1,000 oxygen concentrators last month, and seven oxygen producing plants, one in each province, are being built. These will help to increase health preparation in the event of future pandemic waves.
“We congratulate the Government of Nepal on becoming the first government in South Asia, and one of the first in the world, to join and use the COVAX cost-sharing option,” said Hartwig Schafer, World Bank Vice President for South Asia. “The World Bank remains committed to supporting Nepal’s COVID-19 immunisation campaign, which is important to assisting Nepal’s people and economy in recovering from this extraordinary crisis.”
The World Bank backs countries’ COVID-19 vaccination rollout programmes. Countries make decisions based on their unique needs as well as the WHO’s recommended policy and guidelines for vaccines, medicines, and other instruments. The Bank accepts as eligible for inclusion in the project COVID-19 vaccines that I have received regular or emergency licensure or authorization from at least one of the Stringent Regulatory Authorities (SRAs) identified by the World Health Organization (WHO) for vaccines procured and/or supplied under the COVAX Facility, a vaccine procured and/or supplied under the COVAX Facility, a vaccine procured and/or supplied under the COVAX Facility, a vaccine procure These requirements are met by the Moderna vaccine.